Shah AM, Tarfeen N, Mohamed H, Song Y. Fermented foods: their health-promoting components and potential effects on gut microbiota. Fermentation. 2023;9(2):118.

Article  CAS  Google Scholar 

Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378(9786):169–81.

Article  PubMed  Google Scholar 

Dall TM, Narayan KV, Gillespie KB, Gallo PD, Blanchard TD, Solcan M, et al. Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Popul Health Metrics. 2014;12:1–14.

Article  Google Scholar 

Ellis K, Mulnier H, Forbes A. Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis. BMC Fam Pract. 2018;19(1):1–21.

Article  Google Scholar 

Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr. 2005;25:391–406.

Article  CAS  PubMed  Google Scholar 

Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.

Article  PubMed  Google Scholar 

Pickup J, Crook M. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241–8.

Article  CAS  PubMed  Google Scholar 

Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J. 2012;12(1):5.

Article  PubMed  PubMed Central  Google Scholar 

Tiwari BK, Pandey KB, Abidi A, Rizvi SI. Markers of oxidative stress during diabetes mellitus. J Biomark. 2013;2013.

Wang X, Bao W, Liu J, OuYang Y-Y, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36(1):166–75.

Article  CAS  PubMed  Google Scholar 

Banerjee M, Saxena M. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin Chim Acta. 2012;413(15–16):1163–70.

Article  CAS  PubMed  Google Scholar 

Calle M, Fernandez M. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38(3):183–91.

Article  CAS  PubMed  Google Scholar 

Das M, Pal S, Ghosh A. Family history of type 2 diabetes and prevalence of metabolic syndrome in adult Asian Indians. J Cardiovasc Dis Res. 2012;3(2):104–8.

Article  PubMed  PubMed Central  Google Scholar 

Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111(12):1805–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grossmann V, Schmitt VH, Zeller T, Panova-Noeva M, Schulz A, Laubert-Reh D, et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care. 2015;38(7):1356–64.

Article  CAS  PubMed  Google Scholar 

Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay JL, et al. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine. 2012;57(1):136–42.

Article  CAS  PubMed  Google Scholar 

Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Critical Reviews™ in Eukaryotic Gene Expression. 2017;119(1):105–110.

Google Scholar 

Nesto R. C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med. 2004;21(8):810–7.

Article  CAS  PubMed  Google Scholar 

Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105–10.

Article  CAS  PubMed  Google Scholar 

Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA. Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes. 2015;6(4):598.

Article  PubMed  PubMed Central  Google Scholar 

Smitka K, Marešová D. Adipose tissue as an endocrine organ: an update on pro-inflammatory and anti-inflammatory microenvironment. Prague Med Rep. 2015;116(2):87–111.

Article  PubMed  Google Scholar 

Borst SE. The role of TNF-α in insulin resistance. Endocrine. 2004;23:177–82.

Article  CAS  PubMed  Google Scholar 

Bashir H, Bhat SA, Majid S, Hamid R, Koul RK, Rehman MU, et al. Role of inflammatory mediators (TNF-α, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India. Med J Islam Repub Iran. 2020;34:5.

PubMed  PubMed Central  Google Scholar 

Alzamil H. Elevated serum TNF-α is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance. J Obes. 2020;2020.

Doody NE, Dowejko MM, Akam EC, Cox NJ, Bhatti JS, Singh P, et al. The role of TLR4, TNF-α and IL-1β in type 2 diabetes mellitus development within a North Indian population. Ann Hum Genet. 2017;81(4):141–6.

Article  CAS  PubMed  Google Scholar 

Kanmani S, Kwon M, Shin M-K, Kim MK. Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. Sci Rep. 2019;9(1):4573.

Article  PubMed  PubMed Central  Google Scholar 

Tarfeen N, Nisa KU, Ahmad MB, Waza AA, Ganai BA. Metabolic and Genetic Association of Vitamin D with Calcium Signaling and Insulin Resistance. Indian J Clin Biochem. 2022:1–11.

Dibaba DT. Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis. Nutr Rev. 2019;77(12):890–902.

Article  PubMed  Google Scholar 

Randhawa FA, Mustafa S, Khan DM, Hamid S. Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency. Pak J Med Sci. 2017;33(4):881.

Article  PubMed  PubMed Central  Google Scholar 

Nisa KU, Tarfeen N, Mir SA, Waza AA, Ahmad MB, Ganai BA. Molecular mechanisms in the etiology of polycystic ovary syndrome (PCOS): a multifaceted hypothesis towards the disease with potential therapeutics. Indian J Clin Biochem. 2023:1–19.

Szymczak-Pajor I, Drzewoski J, Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020;21(18):6644.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wimalawansa SJ. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol. 2018;175:177–89.

Article  CAS  PubMed  Google Scholar 

Abbas MA. Physiological functions of Vitamin D in adipose tissue. J Steroid Biochem Mol Biol. 2017;165:369–81.

Article  CAS  PubMed  Google Scholar 

Arafat M, Salam A, Arafat O. The association of Type 2 diabetes with obesity and other factors: in multinational community. Int J Pharm Pharm Sci. 2014;6(9):257–60.

Google Scholar 

Dhodi JB, Mestry SN, Juvekar AR. Diabetic nephropathy-genesis, prevention, and treatment. Int J Pharm Pharm Sci. 2014;6(9):42–7.

Google Scholar 

Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes. 1996;45(6):822–4.

Article  CAS  PubMed  Google Scholar 

Palomer X, González-Clemente J, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10(3):185–97.

Article  CAS  PubMed  Google Scholar 

Rashid T, Bhat S, Wani MU, Majid S, Hassan I, Rashid S, et al. The lipid peroxidation and antioxidant status of type 2 diabetic patients in Kashmir (India). Int J Diabetes Dev Ctries. 2015;35:476–81.

Article  CAS  Google Scholar 

Din I, Majid S, Rashid F, Hussain I, Koul RK, Qadir J, et al. Combinatorial effect of leptin, tumor necrosis factor-αlpha, and vitamin D in progression of type 2 diabetes in Kashmiri population. Asian J Pharm Clin Res. 2018;11:477–81.

Article  CAS  Google Scholar 

Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011;57(1):63–9.

Article  CAS  PubMed  Google Scholar 

Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women. J Inflamm. 2008;5(1):1–9.

Article  Google Scholar 

Moller DE. Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11(6):212–7.

Article  CAS  PubMed  Google Scholar 

Miyazaki Y, Pipek R, Mandarino L, DeFronzo RA. Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients. Int J Obes. 2003;27(1):88–94.

Article  CAS